2023 annual financial data
Lexeo Therapeutics 2023 Operating margin
Lexeo Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -68,513,000 USD and net income was -66,394,000 USD.
Operating cash flow was -59,496,000 USD.
Get free Lexeo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -68,513,000 USD
- Net income
- -66,394,000 USD
- Operating cash flow
- -59,496,000 USD